Prompted by mounting research, advanced imaging technology and growing support from experts in the field, the gastroenterology community has been debating the pros and cons of a paradigm shift in the ...
Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback